動物用ワクチンのヨーロッパ市場2020-2177

◆英語タイトル:EUROPE VETERINARY VACCINES MARKET FORECAST 2020-2028
◆商品コード:INK20MY228
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年2月
◆ページ数:162
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥216,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGS The veterinary vaccines market in Europe is estimated to record a CAGR of 5.76% over the forecast period, 2020-2028. Stringent regulations witnessed in the sustainability of livestock is one of the key factors accelerating the demand for veterinary vaccines in the region.

MARKET INSIGHTS
The European region, with regard to the veterinary vaccines market, is surveyed through the countries of Russia, Germany, Belgium, France, Poland, the UK, Italy, and the rest of Europe that includes the Netherlands, Denmark, Luxembourg, Sweden, Norway, Portugal, and Austria, and Poland. In Italy, the vaccination for Sylvatic rabies became voluntary and compulsory for the dogs, and long-lasting vaccines were highly preferred. Incidences of new infections that provide an opportunity to develop new vaccines, and the increased government initiatives augment the market growth in the country. The Russian Federation Government established the Federal Service for Veterinary and Phytosanitary Surveillance in 2004. In 2018, 63 outbreaks of lumpy skin diseases were reported only in Russia between April and November, confirming the seasonal pattern of LSD. These factors are expected to boost Russia’s market.
In countries like Poland, the Ministry of Agriculture and Rural Development is responsible for the development of rural economy, implementation of the agricultural policy, and the production of safe agricultural products. Several local and regional authorities are collecting data at the primary level to make them available to central authorities. The Netherlands Food and Consumer Product Safety Authority is responsible for controlling animal diseases. The Netherlands is a densely populated country with a large number of pet animals and livestock, and with human activities in close contact with wildlife, it results in a high number of zoonosis cases. The Danish Veterinary and Food Administration is responsible for the prevention and control of animal diseases in Denmark.

COMPETITIVE INSIGHTS
Anicon Labor GmBH, Vaxxinova GmbH, The Boehringer Ingelheim, Ceva Santé Animale, HIPRA, etc. are some of the renowned companies operating in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARIES
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. PROGRESSION IN THE VACCINE PRODUCTS
3.2.2. INCREASING GOVERNMENT INITIATIVES
3.2.3. INCREASING INCIDENCE OF ZOONOTIC DISEASES
3.2.4. SURGE IN THE COMPANION ANIMAL OWNERSHIP
3.2.5. GROWING PREVALENCE OF LIVESTOCK DISEASES
3.3. KEY RESTRAINTS
3.3.1. HIGH COST OF VACCINATIONS
3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
3.3.3. LACK OF SKILLED FARMWORKERS AND VETERINARIANS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. VALUE CHAIN ANALYSIS
4.3. REGULATORY FRAMEWORK
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY VACCINE TYPE
5.1. LIVESTOCK VACCINE
5.1.1. PORCINE VACCINE
5.1.2. BOVINE VACCINE
5.1.3. POULTRY VACCINE
5.1.4. AQUACULTURE VACCINE
5.1.5. OTHER LIVESTOCK VACCINE
5.2. COMPANION VACCINE
5.2.1. CANINE VACCINE
5.2.2. FELINE VACCINE
5.2.3. EQUINE VACCINE
6. MARKET BY TECHNOLOGY
6.1. LIVE ATTENUATED VACCINE
6.2. INACTIVATED VACCINE
6.3. RECOMBINANT VACCINE
6.4. TOXOID VACCINE
6.5. OTHER TECHNOLOGY
7. MARKET BY DISEASE TYPE
7.1. CANINE DISEASE
7.2. PORCINE DISEASE
7.3. BOVINE DISEASE
7.4. POULTRY DISEASE
7.5. AQUACULTURE DISEASE
7.6. OTHER DISEASE TYPE
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. THE UNITED KINGDOM
8.1.2. FRANCE
8.1.3. GERMANY
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. BELGIUM
8.1.7. POLAND
8.1.8. REST OF EUROPE
9. COMPANY PROFILES
9.1. ANICON LABOR GMBH
9.2. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
9.3. CEVA SANTE ANIMALE
9.4. ELANCO (ELI LILLY AND COMPANY)
9.5. HESTER BIOSCIENCES LIMITED
9.6. HIPRA
9.7. HYGIEIA BIOLOGICAL LABORATORIES
9.8. MERCK & CO.
9.9. PHIBRO ANIMAL HEALTH CORP.
9.10. ROMVAC COMPANY S.A.
9.11. VAXXINOVA GMBH-GERMANY
9.12. VIRBAC SA
9.13. ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE
TABLE 2: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: EUROPE LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: EUROPE PORCINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES
TABLE 10: EUROPE PORCINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 11: EUROPE BOVINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES
TABLE 13: EUROPE BOVINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: EUROPE POULTRY VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES
TABLE 16: EUROPE POULTRY VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 17: EUROPE AQUACULTURE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES
TABLE 19: EUROPE AQUACULTURE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: EUROPE OTHER LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: EUROPE OTHER LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: EUROPE COMPANION VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: EUROPE COMPANION VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: EUROPE COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: EUROPE COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: EUROPE CANINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES
TABLE 28: EUROPE CANINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 29: EUROPE FELINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES
TABLE 31: EUROPE FELINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: EUROPE EQUINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES
TABLE 34: EUROPE EQUINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 35: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 37: EUROPE LIVE ATTENUATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: EUROPE LIVE ATTENUATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 39: EUROPE INACTIVATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: EUROPE INACTIVATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 41: EUROPE RECOMBINANT VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 42: EUROPE RECOMBINANT VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 43: EUROPE TOXOID VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 44: EUROPE TOXOID VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 45: EUROPE OTHER TECHNOLOGY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 46: EUROPE OTHER TECHNOLOGY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 47: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 48: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 49: EUROPE CANINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 50: EUROPE CANINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 51: EUROPE PORCINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 52: EUROPE PORCINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 53: EUROPE BOVINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 54: EUROPE BOVINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 55: EUROPE POULTRY DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 56: EUROPE POULTRY DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 57: EUROPE AQUACULTURE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 58: EUROPE AQUACULTURE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 59: EUROPE OTHER DISEASE TYPE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 60: EUROPE OTHER DISEASE TYPE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 61: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 62: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: EUROPE VETERINARY VACCINES, BY VACCINE TYPE, IN 2019
FIGURE 5: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 6: EUROPE LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 7: EUROPE LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 8: EUROPE LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 9: EUROPE LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 10: EUROPE LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 11: EUROPE VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 12: EUROPE COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 13: EUROPE COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 14: EUROPE COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 15: EUROPE VETERINARY VACCINES, BY TECHNOLOGY, IN 2019
FIGURE 16: EUROPE VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 17: EUROPE VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 18: EUROPE VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 19: EUROPE VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 20: EUROPE VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)
FIGURE 21: EUROPE VETERINARY VACCINES, BY DISEASE TYPE, IN 2019
FIGURE 22: EUROPE VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 23: EUROPE VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 24: EUROPE VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 25: EUROPE VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 26: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 27: EUROPE VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)
FIGURE 28: EUROPE VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 29: THE UNITED KINGDOM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 30: FRANCE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 31: GERMANY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 32: ITALY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 33: RUSSIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 34: BELGIUM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 35: POLAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 36: REST OF EUROPE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[動物用ワクチンのヨーロッパ市場2020-2177]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆